RZLT

JMP Securities analyst Jason Butler reiterated a Buy rating on Rezolute (RZLT - Research Report) today and set a price target of $8.00. The company's shares closed yesterday at $2.70.Butler covers the Healthcare sector, focusing on stocks such as Athira Pharma, ACADIA Pharmaceuticals, and Quoin Pharmaceuticals. According to TipRanks, Butler has an average return of -2.1% and a 42.45% success rate on recommended stocks. Rezolute has an analyst consensus of Strong Buy, with a price target consensus of $12.00, representing a 344.44% upside. In a report released on September 12, Jefferies also initiated coverage with a Buy rating on the stock with a $11.00 price target.
https://www.tipranks.com/news/blurbs/rezolute-rzlt-receives-a-buy-from-jmp-securities-2?utm_source=advfn.com&utm_medium=referral